Skip to content

Clinical trials

Phase 4 Neoplasms trials in Czechia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 4 Country / region: Czechia Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20122
20131
20141
20152

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed5
Active, not recruiting1
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals2
Hoffmann-La Roche1
Millennium Pharmaceuticals, Inc.1
Pfizer1
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.1
The Institute of Molecular and Translational Medicine, Czech Republic1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms7
Neuroendocrine Tumors2
Adenoma1
Bone Neoplasms1
Carcinoid Tumor1
Carcinoma1
Colonic Neoplasms1
Hematologic Diseases1
Hodgkin Disease1
Immune System Diseases1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.